Imatinib TDM in GIST

PHASE2RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

March 26, 2024

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions

Gastrointestinal Stromal Tumors

Interventions

DRUG

Imatinib

Therapeutic drug level monitoring with plans to increase to adjust drug dosage based on levels and patient symptoms.

Trial Locations (1)

RECRUITING

Markey Cancer Center, Lexington

All Listed Sponsors

lead

Reema A. Patel

OTHER